Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma.: An analysis of 51 cases and review of the literature

被引:28
作者
Kerbauy, FR
Colleoni, GWB
Saad, STO
Silva, MRR
Alves, AC
Aguiar, KCC
Albuquerque, DM
Kobarg, J
Seixas, MT
Kerbauy, J
机构
[1] Univ Fed Sao Paulo, UNIFESP EPM, Discipline Hematol & Hemotherapy, Sao Paulo, Brazil
[2] Univ Estadual Campinas, Hemoctr UNICAMP, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, UNIFESP EPM, Dept Pathol, Sao Paulo, Brazil
[4] Ctr Biol Mol Estrutural, Lab Nacl Luz Sincrotron, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
non-Hodgkin's lymphomas; P53; protein; p53 gene mutation; prognosis;
D O I
10.1080/10428190410001713170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Although the presence of p53 gene mutations has been considered as a bad prognostic feature in DLBCL, its clinical significance is still controversial. The aims of this study were: detect the presence of mutations in exons 5 to 9 of the p53 gene and correlate it to prognosis in DLBCL. Fifty-one DLBCL patients were enrolled in this study. Expression of p53 was evaluated by immunohistochemistry. The screening of p53 mutations was performed using PCR-SSCP methods. Cases showing a mobility shift on SSCP electrophoresis were analyzed by automatic sequencing. We could identify 8 missense mutations in 6 of 48 cases (12.5%). In addition, we found a known polymorphism at codon 213 and 2 instances of silent mutations. Of all mutations/polymorphisms found, 7 (64%) were localized in codons previously described as p53 hot spots in NHL cases. Of the remaining alterations (4 or 36%), 2 mutations were localized in codons previously described as hot spots for p53 in other tumors and 2 (codon 142 of the exon 5 and codon 195 of the exon 6), in codons not described as hot spots for p53 up to now. The presence of missense mutations in exons 5 to 9 of p53 gene had adverse impact on overall survival (P=0.020). Cox's Regression Model identified that high-risk International Prognostic Index (IPI) and p53 gene mutations have independent negative impact on OS. Therefore, the association of IPI with cellular factors, such as p53 mutation, can be very helpful in deciding when we should indicate more aggressive therapies in patients with DLBCL, to somehow increase the chance of cure in these patients.
引用
收藏
页码:2071 / 2078
页数:8
相关论文
共 37 条
[1]   Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma [J].
Barrans, SL ;
Carter, I ;
Owen, RG ;
Davies, FE ;
Patmore, RD ;
Haynes, AP ;
Morgan, GJ ;
Jack, AS .
BLOOD, 2002, 99 (04) :1136-1143
[2]   CHOP plus rituximab - Balancing facts and opinion. [J].
Cheson, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :280-282
[3]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[4]   p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function [J].
Chilosi, M ;
Doglioni, C ;
Magalini, A ;
Inghirami, G ;
Krampera, M ;
Nadali, G ;
Rahal, D ;
Pedron, S ;
Benedetti, A ;
Scardoni, M ;
Macri, E ;
Lestani, M ;
Menestrina, F ;
Pizzolo, G ;
Scarpa, A .
BLOOD, 1996, 88 (10) :4012-4020
[5]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Apoptosis and the dilemma of cancer chemotherapy [J].
Hannun, YA .
BLOOD, 1997, 89 (06) :1845-1853
[8]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[9]   Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma [J].
Ichikawa, A ;
Kinoshita, T ;
Watanabe, T ;
Kato, H ;
Nagai, H ;
Tsushita, K ;
Saito, H ;
Hotta, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (08) :529-534
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481